Increasing the evidence for surveillance of metastatic renal cancer
- PMID: 33765328
- DOI: 10.1002/cncr.33490
Increasing the evidence for surveillance of metastatic renal cancer
Keywords: active surveillance; focal therapy; oligometastasis; renal cell carcinoma; systemic therapy.
Comment on
-
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).Cancer. 2021 Jul 1;127(13):2204-2212. doi: 10.1002/cncr.33494. Epub 2021 Mar 25. Cancer. 2021. PMID: 33765337 Free PMC article.
References
-
- Harrison MR, Costello GA, Bhavsar NA, et al. Active surveillance of metastatic renal cell carcinoma: results from a prospective observational study (MaRCC). Cancer. 2021;127:2204-2212.
-
- Rini BI, Dorff TB, Elson P, et al. Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial. Lancet Oncol. 2016;17:1317-1324.
-
- de Bruijn RE, Kuusk T, Noe AP, et al. Observation after cytoreductive nephrectomy in patients with synchronous not completely resected metastases of renal cell carcinoma. Urology. 2017;109:127-133.
-
- Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75:799-810.
-
- Sternberg CN, Hawkins RE, Wagstaff J, et al. A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. Eur J Cancer. 2013;49:1287-1296.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical